BSJ-03-204
Modify Date: 2024-01-11 09:52:03
BSJ-03-204 structure
|
Common Name | BSJ-03-204 | ||
|---|---|---|---|---|
| CAS Number | 2349356-09-6 | Molecular Weight | 832.90 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C43H48N10O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BSJ-03-204BSJ-03-204 is a potent and selective Palbociclib-based CDK4/6 dual degrader (PROTAC), with IC50s of 26.9 nM and 10.4 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-03-204 does not induce IKZF1/3 degradation and has anti-cancer activity[1]. |
| Name | BSJ-03-204 |
|---|
| Description | BSJ-03-204 is a potent and selective Palbociclib-based CDK4/6 dual degrader (PROTAC), with IC50s of 26.9 nM and 10.4 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-03-204 does not induce IKZF1/3 degradation and has anti-cancer activity[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK4/D1:26.9 nM (IC50) CDK6/D1:10.4 nM (IC50) |
| In Vitro | BSJ-03-204 (0.0001-100 μM; for 3 or 4 days) has potent anti-proliferative effects on MCL cell lines[1]. BSJ-03-204 (1 μM; for 1 day) potently induces a G1 arrest[1]. BSJ-03-204 (0.1-5 μM; for 4 hours) only resultes in degradation of CDK4/6 in WT cells, not IKZF1/3[1]. Cell Proliferation Assay[1] Cell Line: MCL cell lines (Jeko-1, Mino, Granta-519, Rec-1, and Maver-1 cells) Concentration: 0.0001-100 μM Incubation Time: For 3 or 4 days Result: Had potent anti-proliferative effects on mantle cell lymphoma (MCL) cell lines. Cell Cycle Analysis[1] Cell Line: Granta-519 cells Concentration: 1 μM Incubation Time: For 1 day Result: Potently induced a G1 arrest. Western Blot Analysis[1] Cell Line: Wildtype (WT) or Crbn-/- Jurkat cells Concentration: 0.1, 0.5, 1, 5 μM Incubation Time: For 4 hours Result: Only resulted in degradation of CDK4/6 in WT cells, not IKZF1/3. |
| References |
| Molecular Formula | C43H48N10O8 |
|---|---|
| Molecular Weight | 832.90 |
| Hazard Codes | Xi |
|---|